TIME ABOUT IT’S

MAKING AN IMPACT FOR MEN IN 2024/25 PROSTATE CANCER UK IMPACT REPORT
MAKING AN IMPACT FOR MEN IN 2024/25 PROSTATE CANCER UK IMPACT REPORT
Prostate cancer is the most common cancer in men. In fact, 1 in 8 of our dads, brothers, grandads and mates will be diagnosed with the disease.
Despite this, there’s no national screening programme inviting men for regular tests to help find it early. And that means there are still far too many men being diagnosed when it’s too late. This is our challenge. But thanks to your support this year, we’re leading the way towards a better future for men.
It’s a future where early diagnosis has become the norm, giving men better treatment options. Where a faster, fairer health system is working for every man - regardless of ethnicity or postcode. Where men have more time to do the things they love, with family and friends by their side.
We’re striving to turn this vision into a reality. It’s why we’re raising awareness to make sure every man knows his risk. It’s why we’re funding research to improve the way we diagnose and treat the disease. And it’s why we’re providing vital information and support, giving men the power to navigate prostate cancer.
This was a year in which prostate cancer cut through the public consciousness like never before. High-profile celebrities like Sir Chris Hoy came forward to share their diagnosis, talk publicly about the disease and bang the drum for risk awareness. And at the same time, we spearheaded transformative partnerships with the likes of Omaze, Paddy Power, M&S and the MOBO Awards to reach record numbers of men with our lifesaving message. All while continuing to be the biggest funder of prostate cancer research in the UK, investing in cutting-edge science and innovation to transform men’s health.
But we can only get there with our extraordinary supporters by our side. And that’s what this Impact Report is all about: the difference we’re making together.
So I’d like to say a sincere thank you for standing with us this year and helping us move closer to a world where no man dies of prostate cancer. I hope you enjoy the report.
As the UK’s largest men’s health charity, we’re striving for a world where no man dies of prostate cancer. And we’re on a mission to give every man the power to navigate this complex disease.
Thanks to your continued support, we’ve impacted the lives of millions more men this year. And by raising lifesaving awareness, funding pioneering research and providing vital information and support, we’re continuing to help men find their path through prostate cancer.
Individual donations: £18.7m
Events and community fundraising: £12.8m
Partnerships: £6.4m
Philanthropic gifts: £4.9m
Investments: £2.4m
Merchandise sales: £0.3m
TOTAL INCOME: £45.5m
Research: £14.2m
Raising funds: £11.0m
Raising awareness: £9.8m
Funding our support services: £7.0m
1.5 million more men know their risk of prostate cancer after taking our 30-second Risk Checker
Thousands of men will benefit from advances in diagnosis and treatment driven by our
14 new research grants
Our friendly and compassionate Specialist Nurses were on hand to listen and provide support to men and their loved ones
EXPENDITURE: £42.0m more than 14,000 times
Prostate cancer is now the most common cancer in England – and across the UK, as many as 1 in 8 men will get it.
But if you find it early, it’s much easier to treat. And that’s why we’re striving to make sure every man understands his risk. For Dave Cossie, it turned out to be a lifesaver.
After his twin brother Pete was diagnosed with stage four prostate cancer, Dave knew their Caribbean heritage and family history of the disease meant he was at higher risk. So he decided to get checked too.
Dave’s first PSA blood test showed no concerns. Neither did his second. But
the results of a third test were higher than normal. And later, an MRI scan and biopsy confirmed a stage two diagnosis.
Crucially, Dave found his cancer early, which meant he had treatment options. He chose surgery – and two years later, he’s doing well.
“Opting for removal seemed the best fit for me,” said Dave. “It was a choice my brother unfortunately never had.”
Thankfully, Pete is still with us too. And his positive attitude has been a source of inspiration to his brother.
His positivity is my motivation to raise awareness. We really hope it’s contributed to saving another life.
Finding it early gave me treatment options. It was a choice my brother unfortunately never had.
Dave Cossie, Prostate Cancer UK supporter
Right now, there’s no national screening programme inviting men for regular, accurate tests. And it means there are sadly too many men like Pete being diagnosed when it’s too late for a cure.
That’s why our £42 million TRANSFORM trial is so important. Led by six of the world’s top experts, it will help us find the best way to diagnose prostate cancer – paving the way to a national screening programme.
TRANSFORM is our top priority and will be the biggest trial in prostate cancer screening for two decades, involving hundreds of thousands of men when recruitment gets
under way later this year. It’s our best chance of helping men get a lifesaving early diagnosis.
We’re extremely grateful to our TRANSFORM Founding Partnersthe Garfield Weston Foundation, Movember, Omaze, The Freddie Green and Family Charitable Foundation, NIHR and Paddy Power - whose generous support is helping us drive forward this ambitious research trial.
This is by far the biggest, most exciting trial in prostate cancer screening and diagnosis in over 20 years.
Professor
Hash Ahmed, Imperial College London
We were honoured to receive a £1 million donation for TRANSFORM from the Garfield Weston Foundation this year. Sophia Weston, the Foundation’s Deputy Chair, said: “The trustees are delighted to be collaborating with Prostate Cancer UK on this vital trial, bringing us closer to nationwide screening for prostate cancer.”
There are men like Dave and Pete all over the UK. But thanks to your support, more of them are finding prostate cancer early.
That’s partly because there’s greater awareness today than ever before. In the last 12 months, 1.5 million men have taken our quick and easy online Risk Checker – more than we’ve ever seen in a single year.
At the same time we’ve continued to raise awareness among men at greatest risk – particularly targeting Black men and men in our high priority areas: Scotland, Wales, the South West, the North West and the Midlands.
48,718 Black men took our online Risk Checker
But what does it mean for men? It means they’re waking up to their risk of prostate cancer – and taking action.
Hundreds of thousands more men have found out they’re at higher risk because of their age, ethnicity or family history of the disease – and feel empowered to talk to their GP about having a PSA blood test.
And when it comes to the PSA test, there’s more good news: the majority of men now know this simple blood test –not the digital rectal exam – is the best test to check for early warning signs.
1.5 million total risk checks in 2024/25 2022/23 2023/24 2024/25
Raising awareness is having a big impact in driving early detection. But it’s only part of the solution. To find prostate cancer early, we also need to improve the way we diagnose the disease. And that’s where funding research comes in.
Research like the PRIME trial, which has shown that a streamlined MRI scan can be just as effective at finding prostate cancer as the current gold standard. The findings of this research, which was generously supported by The John Black Charitable Foundation, will speed up the process and make MRI scans cheaper and more readily available.
These quicker scans, which will now be tested as part of our TRANSFORM trial, take around a third less time than the traditional multi-parametric MRI and could significantly reduce waiting times for men.
Working together with partners like Omaze is helping us turn vital research like TRANSFORM from vision to reality.
cheaper to perform.
Men could now be given quicker scans that are just as good and
Dr Matthew Hobbs, Director of Research at
Prostate Cancer UK
In 2024/25, we awarded £1.9 million towards new research, like the PRIME trial, that will improve the way we diagnose prostate cancer and help more men find it earlier
As the charity partner in the Million Pound Surrey House Draw last year, Omaze helped us raise a remarkable £3.45 million in just six weeks – pushing us closer to a world where screening gives more men the chance of a lifechanging early diagnosis. Our partnership with Omaze also drove men towards the Risk Checker, with more than 250,000 men visiting our website to check their risk during the period of the campaign.
Getting men diagnosed earlier isn’t the only challenge we face. Today, some men are at higher risk than others – and our health system is letting them down. So we’re using our growing influence to make sure every man gets the best possible treatment, care and support.
That’s what our Faster Fairer Better campaign is all about. We want to see the Government take urgent action to speed up diagnosis and tackle shocking inequities that are putting Black men’s lives at risk.
51% of the public say they’ve read or heard about Black men over 45 being at higher risk of prostate cancer, up from 41% last year
of MPs surveyed say they support our Faster Fairer Better campaign 2/3
At the heart of the campaign is our call to change outdated NHS guidelines, which would empower GPs to talk to Black men – and others at highest risk – about prostate cancer from the younger age of 45.
Around 10,000 people, including champion boxer Daniel Dubois and former footballer Les Ferdinand,
signed our open letter to the Health Secretary Wes Streeting this year, with a group of MPs joining forces to back our urgent call for action in Parliament too.
Alongside our campaign we’ve also helped establish the first All-Party Parliamentary Group on prostate cancer, bringing together an influential committee of MPs to build further momentum for change.
1 in 4 Black men will get prostate cancer – double the risk of other men 1 in 4
receiving better care and support, thanks to our Clinical Champions of our Clinical Champions felt more confident after completing the programme
17,400 men 100% 180% increase
in clinical capacity for prostate surgery at Royal Surrey NHSFT
With the NHS under pressure, prostate cancer services must be able to adapt and improve to meet men’s needs. And that’s where our clinical education and improvement programmes are having a big impact.
Thanks to your support, more than 17,000 men have directly benefited from on-the-ground
By forging a new partnership with the MOBO Awards this year, we were able to strengthen our connection with Black men and extend our reach in more Black communities.
innovations driven by health professionals who are determined to make a difference through our Clinical Champions programme.
One of these success stories was at the Royal Surrey NHS Foundation Trust, where men who’ve had surgery to remove the prostate were taught by staff to take out
their own catheters at home. This innovation has empowered men to play an active role in their own care, while reducing the need to attend clinic - and creating extra time for other potentially lifesaving prostate removal surgeries.
Working with MOBO founder Kanya King and Prostate
Cancer UK ambassador Tim Campbell, we brought a vital health message to national attention – with media coverage reaching an audience of over 130 million.
Our collaboration provided an unprecedented platform to get our lifesaving risk awareness message to men with the highest risk of prostate cancer – including Black men – while amplifying our urgent campaign to tackle health inequities.
We’re hopeful the treatment will mean we can enjoy more quality time together.
Sharon Flanagan, Prostate Cancer UK supporter
In years to come, a screening programme will drive early diagnosis of prostate cancer - and save thousands more men every year. But today, there are still too many men being diagnosed too late.
And that’s why we’re continuing to invest in research - to pioneer new and better forms of treatment that will give men with advanced prostate cancer more time with their loved ones. Men like John, and his wife Sharon.
When he felt a dull ache in his back, 73-year-old John put it down to age – or perhaps a little too much running. But after watching a documentary about broadcaster Bill Turnbull’s prostate cancer story, he decided to ask his GP for a PSA blood test.
This decision proved to be a lifesaver. Because in February 2023, John was diagnosed with advanced, aggressive prostate cancer. As his cancer spread further up his spine, John’s hormone therapy stopped working. But since then, a mix of other treatments has delivered remarkable results.
John had been virtually immobile and taking strong medication every two hours to manage his pain. But the combination of treatments had a transformative effect, completely eliminating the pain and restoring his mobility.
Though the chemotherapy journey brought complications, John’s wife Sharon says he remains determined to raise awareness.
“We’re hopeful that the chemotherapy will put the cancer cells to sleep for a number of years, so we can enjoy more quality time together. Best of all would be for John to be able to get his running shoes out again!”
John is the most positive person you could ever wish to meet. He’s a wonderful husband, father and grandfather.
Thanks to your support, we’re funding a wide range of research projects to drive forward better treatments and help more people like John and Sharon.
Projects like the TRAP trial, which has shown targeted radiotherapy could offer precious extra time for men with advanced prostate cancer - before they need chemotherapy.
As part of our overall research portfolio, we awarded 14 new grants this year, funding innovative science that will drive forward groundbreaking improvements in the diagnosis and treatment of prostate cancer. Our further investment in research this year means we now have a total of 60 active grants.
In the trial, researchers used a precise technique called stereotactic body radiotherapy alongside hormone therapy to treat men whose cancer had begun to grow after previous hormone therapy treatment. The additional radiotherapy targets the tumours that have become resistant, boosting the treatment’s effectiveness.
The results have been impressive. Men who took part in the trial gained an average of six extra months before their cancer progressed again, with over 40 per cent showing no progression at all after a year.
And we’re now funding the larger STAR-TRAP trial, which could lead to better treatment for men with advanced prostate cancer nationwide.
towards Career Support Fellowships, helping researchers launch their careers in prostate cancer
towards Research Innovation Awards, funding innovative research projects to improve diagnosis and treatment of the disease
towards Transformational Impact Awards, moving exciting ideas from the lab to the clinic so men can benefit sooner
Our Specialist Nurses were on hand to listen and answer questions more than 14,000
Alongside the latest research breakthroughs, our support and information services were vital for men and their families whose lives have been touched by prostate cancer this year.
We expanded our Sexual Support Service, launched online hormone therapy classes and our new Risk Information Service helped people with questions about their risk and the PSA blood test on more than 600 occasions
77%
of people surveyed understood their situation better after talking to our Specialist Nurses
When I rang, it was the first time I’d spoken to anyone about prostate cancer. They were so patient and understanding.
89% phone calls made of people surveyed understood their situation better 500
Meanwhile, volunteers with our One-to-One Peer Support Service - generously supported by ICAP and The IMP Trust - enabled hundreds of people to connect with others who’ve been through a similar experience.
On top of all this, our online health information resources were viewed more than 1.2 million times, while hundreds of thousands of men received copies of our printed publications to read at home.
When Melissa lost her husband Allan to prostate cancer, she’d already spent five years navigating his cancer journey. Knowing little about the disease, she found essential support in our information booklets. This filled crucial gaps in her knowledge of treatment side effects, both physical and emotional.
Melissa gradually built her confidence by talking to our Specialist Nurses, accessing support whenever she needed it – to help Allan through his treatment.
Together, they felt empowered to raise awareness, helping one of their friends catch prostate cancer at an early, curable stage.
We’re grateful for the incredible contribution of our many partners, funders and supporters this year. Their collaboration and support has helped us reach millions of men, while raising vital funds to drive forward our work. We’d like to say a very special thank you to the following organisations and individuals – who’ve each helped us make a big impact for men and families affected by prostate cancer this year:
Alice and Richard Rossiter
Andrew Pitt
Angela Milne
Ashley Jones
Bob Willis Fund
Bothwell Charitable Trust
Brew York
Cecil Pilkington Charitable Trust
Charles Tyrwhitt
David Sullivan
Doncaster Rovers FC
Douglas Cooke
Dudley and Geoffrey Cox Charitable Trust
Essity UK
Florian Charitable Trust
Garfield Weston Foundation
Gerry Pack
Howard Lloyd
HowDidiDo Media Ltd
Ian Jackson
Iceland Foods Charitable Foundation
Infinis Energy
John Bloor OBE
John Warren Jones
Ladbrokes Coral Trust
Lazard Asset Management
League Managers Association
Lochlands Trust
Lord Leverhulme’s Charitable Trust
Malcolm Strong
Marks & Spencer
Marston’s PLC
Matchroom Sport Foundation
Michael Metcalf
Mike Tye
MIVA Foundation
MOBO Awards
Moss
Mrs J B Wood’s Charitable Trust
Omaze UK
Orbital Fasteners
Order of Friars Minor Provincial Curia
Paddy Power
Panayiotis Sinnos
Paul Dennington
Paul Thompson
Peacock Charitable Trust
Pentel Stationery
Peter Stormonth Darling Charitable Trust
phs Group
Professional Darts Corporation
Professional Golfers Association
Prostate United
Queens Park Rangers FC
R J and A H Daniels Charitable Trust
Ralph and Elizabeth Aldwinckle
Roger Wiltshire
ShareGift
Sheffield Wednesday FC
Sky Sports
Steve James
talkSPORT
The 3Ts Charitable Trust
The A and R Woolf Charitable Trust
The Beare83 Foundation
The Betting and Gaming Council
The Constance Travis Charitable Trust
The Cranbrook Foundation
The Fieldrose Charitable Trust
The Freddie Green And Family Charitable Foundation
The Grace Trust
The Henry Lumley Charitable Trust
The IMP Trust
The Jane & James Kessler Family Charitable Trust
The John Black Charitable Foundation
The Joron Charitable Trust
The Joseph and Lilian Sully Foundation
The Kenneth & Susan Green Charitable Foundation
The Lord Leonard and Lady Estelle
Wolfson Foundation
The Louis and Valerie Freedman Charitable Settlement
The Mike Gooley Trailfinders Charity
The National League
The Patrick & Helena Frost Foundation
The Pickup Family
The Rose Foundation
The Simon Gibson Charitable Trust
The Sunset Charitable Trust
The W A Handley Charity Trust
The Willie and Mabel Morris Charitable Trust
The Wyfold Charitable Trust
Thomas Allen
Tom and Sheila
Springer Charity
Tottenham Hotspur FC
Tyre Pros
Wolverhampton
Wanderers FC
With more than 900 maximums and two magical nine-dart legs, we’d like to thank Paddy Power for hitting extraordinary new heights at Alexandra Palace this year. Donating £1,000 for every 180 during the tournament, plus a huge bonus for each perfect leg, The BIGGER 180 campaign raised over £1 million towards our TRANSFORM trial - with 180,000 people checking their risk during our campaign.
A remarkable £1 million donation from The Freddie Green and Family Charitable Foundation ignited a hugely successful matched funding campaign this year. Their generous pledge to double every donation made by our incredible supporters unlocked a phenomenal £2 million. This vital funding propelled our groundbreaking TRANSFORM trial forward, bringing the reality of a national screening programme ever closer.
and Sir Chris Hoy: a ‘brief check’ to save men’s lives
We’re grateful to Marks & Spencer, whose national campaign earlier this year raised a six-figure sum to support our work – as well as inspiring tens of thousands of men across the country to check their risk. Backed by Olympic legend Sir Chris Hoy, the UK’s largest retailer encouraged men to take a ‘brief check’ for prostate cancer and pledged £4 for every sale of Autograph men’s underwear. In just six weeks they sold 40,000 packs of pants, raising over £155,000, with 180,000 people taking the Risk Checker during this period.
The Mike Gooley Trailfinders Charity has been supporting us for a remarkable 28 years. Their outstanding commitment has been instrumental in our efforts to raise awareness and accelerate research. This year, we were honoured to receive a transformational £2 million gift from their charity, enabling us to invest even more in pioneering research to change the lives of men and their families.
Inspired by the impact we’ve made in 2024/25?
Scan the code or visit prostatecanceruk.org/ir-impact to learn more about our plans for the year ahead.